Clinical Trials Browser

Phase 2/3 × Completed × Zoledronic Acid × Clear all

NCT01006395 2019-07-05

Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)

Phase 2/3 Completed

Insulin Resistance, Prostatic Neoplasms

NCT01344967 2015-06-23

SuBDuE

Phase 2/3 Completed

Metastatic Breast Cancer With Bone Involvement

NCT00524849 2010-09-14

Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis

Phase 2/3 Completed

Breast Neoplasms